On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Antibiotic resistance in hospitals
- Antibiotic resistance in the community
- The pre-antibiotic era
- The first antibiotics
- Penicillin (1)
- Penicillin (2)
- Penicillin - structure
- Tuberculosis
- Streptomycin
- Trials of streptomycin
- Streptococcus pneumoniae (1)
- Streptococcus pneumoniae (2)
- Multidrug resistant pneumococci
- Multidrug resistant clones
- Staphylococcus aureus
- S. aureus disease
- Spread of MRSA
- MRSA bacteraemia as % in blood cultures
- European distribution of MRSA
- Increasing resistance
- Worldwide MRSA prevalence
- Treatment of MRSA
- The benefits of antibiotics
- The extent of resistance in the UK
- Causes of resistance - mutation
- Causes of resistance - gene transfer
- Increased use leads to more resistance
- Antibiotic classes - beta-lactams
- Antibiotic classes - glycopeptides
- Antibiotic classes - Aminoglycosides
- Antibiotic classes - Fluoroquinolones
- Antibiotic classes - Macrolides
- Antibiotic classes- trimethoprim and tetracyclines
- Other antibiotic classes
- Antibiotic agents in the community and hospitals
- Antimicrobial use and selection for resistance
- The threat
- Implications of inappropriate antibacterial therapy
- Why no new antibiotics?
Topics Covered
- Antibiotic resistance in hospitals
- Antibiotic resistance in the community
- The pre-antibiotic era
- Penicillin
- Tuberculosis
- Streptomycin
- Streptococcus pneumoniae
- Multidrug resistant pneumococci
- Staphylococcus aureus
- Spread of MRSA
- European and worldwide distribution of MRSA
- Treatment of MRSA
- The benefits of antibiotics
- The extent of bacterial resistance in the UK
- Causes of resistance
- Antibiotic classes
- The pyramids for antimicrobial use and selection for antimicrobial resistance
- The threat
- Why no new antibiotics?
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Enright, M. (2009, December 31). Methicillin resistant S. aureus and other resistances [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/EEYY5947.Export Citation (RIS)
Publication History
- Published on December 31, 2009
Financial Disclosures
- Prof. Mark Enright has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.